Immunomic Therapeutics’ continued investment in Process Development provides value in several ways. Internally, we are able to supply the R&D Team with UNITE® products in a timely manner for their ongoing oncology studies. Additionally, our expanded capabilities allow us to work with our corporate partners to better understand and develop the manufacturing process and product testing assays.
